PecFent® is a nasally administrated spray which contains PecSys®. PecFent® is designed to optimise the absorption of fentanyl, matching drug absorption and clinical effect to the profile of a break through cancer pain episode experienced by cancer patients who are already receiving opioid analgesics for chronic pain.

Marketed by Kyowa Kirin in

Marketed by Kyowa Kirin International in